Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Cash from Financing Activities (2020 - 2023)

Cullinan Therapeutics has reported Cash from Financing Activities over the past 4 years, most recently at $248000.0 for Q4 2023.

  • Quarterly results put Cash from Financing Activities at $248000.0 for Q4 2023, up 100.75% from a year ago — trailing twelve months through Dec 2023 was $40.8 million (up 257.14% YoY), and the annual figure for FY2025 was $1.1 million, down 99.59%.
  • Cash from Financing Activities for Q4 2023 was $248000.0 at Cullinan Therapeutics, up from $112000.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for CGEM hit a ceiling of $264.6 million in Q1 2021 and a floor of -$32.9 million in Q4 2022.
  • Median Cash from Financing Activities over the past 4 years was $1.8 million (2023), compared with a mean of $28.2 million.
  • Biggest five-year swings in Cash from Financing Activities: plummeted 1318.06% in 2022 and later skyrocketed 1817.64% in 2023.
  • Cullinan Therapeutics' Cash from Financing Activities stood at $124.9 million in 2020, then tumbled by 97.84% to $2.7 million in 2021, then plummeted by 1318.06% to -$32.9 million in 2022, then surged by 100.75% to $248000.0 in 2023.
  • The last three reported values for Cash from Financing Activities were $248000.0 (Q4 2023), $112000.0 (Q3 2023), and $38.6 million (Q2 2023) per Business Quant data.